JBIO Operating Cash Flow
-$123.51MTTM · USD
Period ending:
JBIO FY Operating Cash FlowUSD
$0.00-$94.69M
2020-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
JBIO operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -94,689,000 | |
| -71,196,000 | |
| -56,778,000 | |
| -39,122,000 | |
| -27,399,000 | |
| -7,859,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All JBIO financial metrics · JBIO stock overview · How to interpret financial metrics
